Relief Therapeutics Holding AG (RLFTF)

[nelskof]

Yes, they did a comparison against 30 patients in a white paper before.
This is comparing 24 control patients in the same setting.

I'd suggest this is the most important part of the PR:

While the number of patients treated at Houston Methodist is modest, the initial results in our nationwide expanded access program suggest similarly encouraging survival with RLF-100™. We continue to closely monitor treatment with RLT-100TM in other hospitals.